Current Edition

Challenges with Cash Management and Reforecasting Clinical Trials
Editorial Archive

Challenges with Cash Management and Reforecasting Clinical Trials

Clinical trials are becoming increasingly complex, particularly with broader scopes, globalisation, changing and expanding regulatory requirements and a greater numbe...
Continue Reading →
Pre-clinical Data Analysis Ensuring Relevant First-in-Human Clinical Trials
Editorial Archive

Pre-clinical Data Analysis Ensuring Relevant First-in-Human Clinical Trials

The first-in-human trial (FIH) is an important milestone in the development of a potential new drug. Nariné Baririan at SGS discusses how going ahead with something t...
Continue Reading →
E.coli in Urinary Tract Infections from 2000–2016
Editorial Archive

E.coli in Urinary Tract Infections from 2000–2016

Urinary tract infection (UTI) is one of the most common infectious diseases and the most common nosocomial infection in the developed world. Complicated urinary tract...
Continue Reading →
Updated Research Criteria for Clinical Trials Across the Alzheimer’s Disease Continuum
Editorial Archive

Updated Research Criteria for Clinical Trials Across the Alzheimer’s Disease Continuum

The National Institute of Aging and Alzheimer’s Association (NIAAA) have recently proposed a common research framework to help investigators establish a research agen...
Continue Reading →
Thinking Big: SCAPIS – The Ideal Cohort for Studies on CVD, COPD and Related Metabolic Disorders
Editorial Archive

Thinking Big: SCAPIS – The Ideal Cohort for Studies on CVD, COPD and Related Metabolic Disorders

Cardiopulmonary diseases are major causes of death worldwide, but currently recommended strategies for diagnosis and prevention are believed to be outdated because of...
Continue Reading →
Acne vulgaris and Associated Impact on Quality of Life
Editorial Archive

Acne vulgaris and Associated Impact on Quality of Life

Acne vulgaris or ‘Pimples' is a very common inflammatory skin disease affecting young adults all over the world, irrespective of race, ethnicity and geographical loca...
Continue Reading →
Improving the Performance of Clinical Trials
Editorial Archive

Improving the Performance of Clinical Trials

Several metrics systems exist to measure performance. The most significant parameters, however, are the course of patient recruitment, how many patients complete the ...
Continue Reading →
Gathering Substantial Data for Faster Clinical Trial Approval
Editorial Archive

Gathering Substantial Data for Faster Clinical Trial Approval

Pharmaceutical manufacturers have long struggled to create an efficient clinical trial process for faster next-phase approval. The root cause of most failures is a la...
Continue Reading →
Customised Supply Solutions for Investigator-initiated Trials
Editorial Archive

Customised Supply Solutions for Investigator-initiated Trials

Investigator-initiated Trials (IITs) are an integral and increasingly important part of the clinical research landscape. In this article, John Denier at Clinigen disc...
Continue Reading →
Collaborating with Patients for Better Trial Design
Editorial Archive

Collaborating with Patients for Better Trial Design

Modern patients are taking control of their own healthcare, from sharing information with one another to approaching industry organisations with their concerns. Tarqu...
Continue Reading →